The post Florida Senate Passes Unprecedented, Comprehensive Stablecoin Regulation appeared first on Coinpedia Fintech News On March 6, the Florida Senate unanimouslyThe post Florida Senate Passes Unprecedented, Comprehensive Stablecoin Regulation appeared first on Coinpedia Fintech News On March 6, the Florida Senate unanimously

Florida Senate Passes Unprecedented, Comprehensive Stablecoin Regulation

2026/03/07 09:50
2 min read
For feedback or concerns regarding this content, please contact us at [email protected]
Hong Kong’s New Stablecoin Law Takes Effect

The post Florida Senate Passes Unprecedented, Comprehensive Stablecoin Regulation appeared first on Coinpedia Fintech News

On March 6, the Florida Senate unanimously passed Bill 314, which details comprehensive regulations regarding payment stablecoins. The pro-crypto state is the first in the US to develop such a framework, which now awaits signing into law by Governor Ron DeSantis.

Florida Senate passes stablecoin legislation

Florida’s framework borrows greatly from the nation’s GENIUS Act to remain federally compliant.

The Bill clarifies that stablecoins are not securities, but that their monetary value makes their issuers Money Services Businesses. This part of the Bill is similar to the specifications made by Texas and New York regarding stablecoins.

Issuers are therefore required to obtain operational licenses, such as the state MSB license or certain certificates of approval, in line with anti-money laundering provisions.

Providers must also perform KYC (Know Your Client) checks and keep real-time records of all transactions, just like banks. Issuers should report transactions above $10,000 to the state and those attracting suspicion to the Florida Office of Financial Regulation (OFR). They should also maintain a 1:1 reserve and transition into federal oversight once their total valuation reaches $10 billion.

In matters of stablecoin yield farming, the legislation says stablecoin issuers must not pay interest to holders if prohibited by federal law. This throws the ball back again to the US Senate, a place where the subject has been greatly debated and remains undecided.

Delays in the CLARITY Act

Some crypto opinionists argue that the GENIUS Act only prohibits issuers from offering stablecoin interest, and not any other rewards. Banks face criticism from US President Donald Trump and his son Eric Trump for lobbing against stablecoin yields, fearing capital flight.

Meanwhile, Tether has now participated in a $7.5 million funding round to build APIs that enable USDT payments on the Bitcoin network. Also developing is USDC, which is now the liquidity reserve for Cardano’s stablecoin USDCx.

The overall stablecoin market cap is now $312.85 billion, having risen from $205 billion in January of 2025.

Chart of stablecoin market cap

Source: DefiLlama

Market Opportunity
RONIN Logo
RONIN Price(RON)
$0.09046
$0.09046$0.09046
-0.50%
USD
RONIN (RON) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09